Compare
TransMedics Group, Inc. vs Conmed Corp vs Medtronic plc
| Latest fiscal year | TransMedics Group, Inc. TMDX | Conmed Corp CNMD | Medtronic plc MDT |
|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-04-24 |
| Revenue | $605.49M | $1.37B | $36.36B |
| Revenue growth (YoY) | +37.1% | +5.2% | +8.4% |
| Gross margin | 59.9% | 54.6% | 65.0% (computed) |
| Operating margin | 17.9% | 7.5% | 17.8% |
| Net margin | 31.4% | 3.4% | 13.2% |
| Net income | $190.29M | $47.05M | $4.80B |
| EPS (Diluted) | $4.87 | $1.51 | $3.73 |
| Operating cash flow | $192.84M | $170.69M | $7.33B |
| Free cash flow | $133.59M | $150.88M | $5.43B |
| Cash & equivalents | n/a | n/a | $1.95B |
| Total assets | $1.07B | $2.33B | $93.03B |
| Total liabilities | $595.27M | $1.29B | $42.96B |
| Shareholders' equity | $473.10M | $1.03B | $49.46B |
| Return on year-end equity | 40.2% | 4.6% | 9.7% |
| Shares outstanding | 34.27M | n/a | 1.28B |
Revenue, most recent five fiscal years
| Fiscal year | TransMedics Group, Inc. | Conmed Corp | Medtronic plc |
|---|---|---|---|
| Latest | $605.49M Ended 2025-12-31 | $1.37B Ended 2025-12-31 | $36.36B Ended 2026-04-24 |
| 1 year earlier | $441.54M Ended 2024-12-31 | $1.31B Ended 2024-12-31 | $33.54B Ended 2025-04-25 |
| 2 years earlier | $241.62M Ended 2023-12-31 | $1.24B Ended 2023-12-31 | $32.36B Ended 2024-04-26 |
| 3 years earlier | $93.46M Ended 2022-12-31 | $1.05B Ended 2022-12-31 | $31.23B Ended 2023-04-28 |
| 4 years earlier | $30.26M Ended 2021-12-31 | $1.01B Ended 2021-12-31 | $31.69B Ended 2022-04-29 |